Here are three things to know.
- The FDA first approved Actemra in 2010 as a treatment for rheumatoid arthritis.
- The drug may now be used to treat adults with giant cell arteritis — a chronic and potentially fatal autoimmune condition caused by inflammation of large and medium-sized arteries in the head or aorta.
- Actemra represents the first FDA-approved treatment for giant cell arteritis.
More articles on supply chain:
McKesson 2017 revenue up 4%: 5 things to know
What Trump’s budget proposal means for FDA funding
Baking soda shortage forces hospitals to postpone surgeries, treatments
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
